Tetrahydrocurcumin for major depressive disorder with therapeutic potential and mechanistic insights from clinical and preclinical studies

Published: 12 May 2025| Version 1 | DOI: 10.17632/mnxnr64vg3.1
Contributor:
Ying Guo

Description

The data includes: proteomics data, behavioral data, immunofluorescence (prefrontal) data, immunofluorescence (hippocampus) data, and serum ELISA data.

Files

Categories

Depression

Licence